Clinical Trials Directory

Trials / Completed

CompletedNCT02821546

Aggressive Fluid Hydration for the Prevention of Post-ERCP Pancreatitis

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
286 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Aggressive hydration with lactated Ringer's solution (LRS) has been shown in a preliminary research to reduce the incidence of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. This randomized, controlled trial was designed to assess the effect of peri-procedural aggressive intravenous hydration with LRS on the incidence of post ERCP pancreatitis.

Detailed description

Patients underwent first-time ERCP were randomly assigned (1:1) to receive either LRS at a rate of 150 ml/hr starting 2 hours prior to procedure, and continued during and after procedure to complete 24 hours (aggressive hydration) or LRS at a rate calculated by the Holliday-Segar method given peri-procedurally as described earlier (standard hydration). Visual analog scale, serum amylase, lipase, C-reactive protein (CRP), and urine analysis were assessed prior to procedure and 24 hours after. The primary endpoint was post ERCP pancreatitis defined as new or increased epigastric pain persisting for ≥24 hours, elevation of amylase or lipase \>3 times the upper limit of normal.

Conditions

Interventions

TypeNameDescription
DRUGLactated Ringer's solutionStandard fluid hydration with Lactated Ringer's solution is calculated based on Holiday Segar's equation Aggressive hydration with Lactated Ringer's solution is defined as administration of 150 ml/hour of fluid

Timeline

Start date
2014-08-01
Primary completion
2017-02-01
Completion
2017-02-01
First posted
2016-07-01
Last updated
2017-03-28

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT02821546. Inclusion in this directory is not an endorsement.